Literature DB >> 1667487

Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.

D R Ciocca1, E H Luque.   

Abstract

Previous studies have shown several similarities between an estrogen-regulated heat shock protein of 24,000-28,000 daltons (hsp27), and a cytoplasmic estrogen receptor-associated protein of 27,000-29,000 daltons (p29). These proteins have been studied by monoclonal antibodies generated in different laboratories. In the present report we have performed immunocytochemical and immunoblot studies to explore if the monoclonal antibodies against hsp27 (C11) and against p29 (ER-D5) may be identifying the same protein. Breast and endometrial carcinomas and normal endometrial samples were examined by immunocytochemistry (in mirror sections and by double-immunostaining). Identical hsp27 and p29 immunostaining intensity, distribution, and percentage of stained cells was demonstrated by immunocytochemistry. The antigens examined by the two antibodies appeared in the same cells. Cytosols from tumors analyzed by the Western blot technique revealed that the C11 and the ER-D5 antibodies recognized bands with identical electrophoretic mobility. Immunoprecipitation studies with one antibody, C11, followed by Western blot showed that the precipitate was reactive with both antibodies. Identical C11 and ER-D5 reacting spots were observed after blotting proteins separated by high resolution two-dimensional gel electrophoresis. In addition, p29 protein was induced by heat shock in the estrogen receptor negative MDA-MB-231 human breast tumor cell line. These results strongly suggest that the two proteins under investigation are identical.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667487     DOI: 10.1007/bf01833355

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

1.  A 90,000-dalton binding protein common to both steroid receptors and the Rous sarcoma virus transforming protein, pp60v-src.

Authors:  S Schuh; W Yonemoto; J Brugge; V J Bauer; R M Riehl; W P Sullivan; D O Toft
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

2.  Expression of an estrogen-regulated protein in rat testis Leydig cells.

Authors:  D R Ciocca; C A Winters; M L Dufau
Journal:  J Steroid Biochem       Date:  1986-01       Impact factor: 4.292

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Heat shock and the heat shock proteins.

Authors:  R H Burdon
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

5.  Characterization of p29, an estrogen-receptor associated tumor marker.

Authors:  A I Coffer; R J King
Journal:  J Steroid Biochem       Date:  1988-11       Impact factor: 4.292

6.  Purification of an estrogen-regulated breast cancer protein by monoclonal antibody affinity chromatography.

Authors:  D J Adams; H Hajj; K G Bitar; D P Edwards; W L McGuire
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

7.  Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies.

Authors:  D R Ciocca; D J Adams; R J Bjercke; D P Edwards; W L McGuire
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

8.  The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma.

Authors:  J D Harrison; D L Morris; I O Ellis; J A Jones; I Jackson
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

9.  Tumor necrosis factor induces the rapid phosphorylation of the mammalian heat shock protein hsp28.

Authors:  A P Arrigo
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

10.  Characterization and biological relevance of a 29-kDa, oestrogen receptor-related protein.

Authors:  R J King; J R Finley; A I Coffer; R R Millis; R D Rubens
Journal:  J Steroid Biochem       Date:  1987       Impact factor: 4.292

View more
  9 in total

1.  Biochemical requirements for the expression of heat shock protein 72 kda in human breast cancer MCF-7 cells.

Authors:  J G Kiang; I D Gist; G C Tsokos
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.

Authors:  R D Whelan; B T Hill
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Regulation of heat shock protein 72 kDa and 90 kDa in human breast cancer MDA-MB-231 cells.

Authors:  J G Kiang; I D Gist; G C Tsokos
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 4.  Heat shock proteins and drug resistance.

Authors:  S A Fuqua; S Oesterreich; S G Hilsenbeck; D D Von Hoff; J Eckardt; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 5.  William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

Authors:  R J King
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 6.  Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation.

Authors:  Zarah Batulan; Vivek Krishna Pulakazhi Venu; Yumei Li; Geremy Koumbadinga; Daiana Gisela Alvarez-Olmedo; Chunhua Shi; Edward R O'Brien
Journal:  Front Immunol       Date:  2016-07-26       Impact factor: 7.561

7.  A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer.

Authors:  S Love; R J King
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

Review 8.  Do heat shock proteins have a role in breast cancer?

Authors:  S E Conroy; D S Latchman
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

9.  HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.

Authors:  André-Patrick Arrigo; Benjamin Gibert
Journal:  Cancers (Basel)       Date:  2014-02-07       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.